7 Innovative Drugs Leading the Fight Against Ulcerative Colitis
Ozanimod introduces sphingosine-1-phosphate receptor modulation via oral administration. By restricting lymphocyte trafficking to intestinal tissue, it provides an innovative therapeutic mechanism for sustained UC control
